HIV-associated primary pulmonary hypertension: A case control study

American Journal of Respiratory and Critical Care Medicine

Volumn 155, Issue 3, 1997, Pages 990-995

  Opravil, Milos ^a   Pechère, Marc ^a   Speich, Rudolf ^a   Joller Jemelka, Helen I ^a   Jenni, Rolf ^a   Russi, Erich W ^a   Hirschel, Bernard ^a   Lüthy, Ruedi ^a   Battegay, M ^e   Burgisser Ph ^e   Doorly, R ^e   Egger, M ^e   Erb, P ^b   Fierz, W ^e   Flepp, M ^c   Francioli, P ^d   Grob, P ^e   Gruninger U ^e   Hirschel, B ^e   Ledergerber, B ^e   Luthy R ^e   Malinverni, R ^e   Matter, L ^e   Opravil, M ^e   Paccaud, F ^e   Perrin, L ^e   Pichler, W ^e   Rickenbach, M ^f   Rutschmann, O ^e   Vernazza, P ^e   Von Overbeck, J ^e   more..

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b Group Laboratories

^c Group Clinics

^d LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^e FOPH ^*

^f Data Center

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; CARDIOLIPIN ANTIBODY; NEOPTERIN; THYROTROPIN;

ADULT; ARTICLE; AUTOIMMUNITY; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HEMODYNAMICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MALE; MORTALITY; PRESSURE GRADIENT; PRIORITY JOURNAL; PULMONARY HYPERTENSION; STATISTICS;

EID: 15444354123     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.155.3.9117037     Document Type: Article

References (35)

1. Rubin, L. J. 1993. Primary pulmonary hypertension. Chest 104:236-250.
2. Goldsmith, G. H. J., R. G. Baily, D. B. Brettler, W. R. J. Davidson, J. O. Ballard, T. E. Driscol, J. M. Greenberg, C. K. Kasper, P. H. Levine, and O. D. Ratnoff. 1988. Primary pulmonary hypertension in patients with classic hemophilia. Ann. Intern. Med. 108:797-799.
3. Himelman, R. B., M. Dohrmann, P. Goodman, N. B. Schiller, N. F. Starksen, M. Warnock, and M. D. Cheitlin. 1989. Severe pulmonary hypertension and cor pulmonale in the acquired immunodeficiency syndrome. Am. J. Cardiol. 64:1396-1399.
4. Coplan, N. L., R. Y. Shimony, H. L. Ioachim, J. R. Wilentz, D. H. Posner, A. Lipschitz, R. A. Ruden, M. S. Bruno, M. V. Sherrid, H. Gaetz, A. Englard, M. Kukin, and M. Packer. 1990. Primary pulmonary hypertension associated with human immunodeficiency viral infection. Am. J. Med. 89:96-99.
5. Speich, R., R. Jenni, M. Opravil, M. Pfab, and E. W. Russi. 1991. Primary pulmonary hypertension in HlV infection. Chest 100:1268-1271.
6. Mette, S. A., H. I. Palevsky, G. G. Pietra, T. M. Williams, E. Bruder, A. J. Prestipino, A. M. Patrick, and J. A. Wirth. 1992. Primary pulmonary hypertension in association with human immunodeficiency virus infection: a possible viral etiology for some forms of hypertensive pulmonary arteriopathy. Am. Rev. Respir. Dis. 145:1196-1200.
7. Petitpretz, P., F. Brenot, R. Azarian, F. Parent, B. Rain, P. Herve, and G. Simonneau. 1994. Pulmonary hypertension in patients with human immunodeficiency virus infection. Comparison with primary pulmonary hypertension. Circulation 89:2722-2727.
8. Weiss, J. R., G. G. Pietra, and S. M. Scharf. 1995. Primary pulmonary hypertension and the human immunodeficiency virus. Report of two cases and a review of the literature. Arch. Intern. Med. 155:2350-2354.
9. Pietra, G. G., W. D. Edwards, J. M. Kay, S. Rich, J. Kernis, B. Schloo, S. M. Ayres, E. H. Bergofsky, B. H. Brundage, K. M. Detre, A. P. Fishman, R. M. Goldring, B. M. Groves, P. S. Levy, L. M. Reid, C. E. Vreim, and G. W. Williams. 1989. Histopathology of primary pulmonary hypertension. A qualitative and quantitative study of pulmonary blood vessels from 58 patients in the National Heart, Lung, and Blood Institute Primary Pulmonary Hypertension Registry. Circulation 80:1198-1206.
10. Letvin, N. L., and N. W. King. 1990. Immunologie and pathologic manifestations of the infection of rhesus monkeys with simian immunodeficiency virus of macaques. J. Acquir. Immune Defic. Syndr. 3:1023-1040.
11. Gillespie, M.N., C. L. Hartsfield, W. N. O'Connor, and D. A. Cohen. 1994. Pulmonary hypertension in a murine model of the acquired immunodeficiency syndrome. Am. J. Respir. Crit. Care Med. 150:194-199.
12. Isern, R. A., M. Yaneva, E. Weiner, A. Parke, N. Rothfield, D. Dantzker, S. Rich, and F. C. Arnett. 1992. Autoantibodies in patients with primary pulmonary hypertension: association with anti-Ku. Am. J. Med. 93:307-312.
13. Yanai Landau, H., H. Amital, Y. Bar Dayan, Y. Levy, H. Gur, H. C. Lin, I. J. Alosachie, J. B. Peter, and Y. Shoenfield. 1995. Autoimmune aspects of primary pulmonary hypertension. Pathobiology 63: 71-75.
14. Badesch, D. B., K. M. Wynne, S. Bonvallet, N. F. Voelkel, C. Ridgway, and B. M. Groves. 1993. Hypothyroidism and primary pulmonary hypertension: an autoimmune pathogenetic link? Ann. Intern. Med. 119:44-46.
15. Chin, R. G., and J. Fisher. 1986. Hypothyroidism and pulmonary hypertension: observation and speculation. Cardiovasc. Rev. Rep. 7:789-796.
16. Kopelman, R. G., and S. Zolla Pazner. 1988. Association of human immunodeficiency virus infection and autoimmune phenomena. Am. J. Med. 84:82-88.
17. Bernard, C., B. Exquis, G. Reber, and P. de Moerloose. 1990. Determination of anti-cardiolipin and other antibodies in HIV-1-infected patients. J. Acquir. Immune Defic. Syndr. 3:536-539.
18. Matsuda, J., K. Gohchi, H. Hama, M. Tsukamoto, N. Saitoh, and T. Kinoshita. 1993. High prevalence of anti-cardiolipin antibody, Clq-, C3d-, and mRF-IgG immune complexes, and anti-nuclear antibody in hemophiliacs irrespective of infection with human immunodeficiency virus type 1. J. Acquir. Immune Defic. Syndr. 6:1120-1124.
19. Ledergerber, B., J. von Overbeck, M. Egger, R. Lüthy, and the Swiss HIV Cohort Study (SHCS). 1994. The Swiss HIV cohort study: rationale, organization and selected baseline characteristics. Soz. Praventivmed. 39:387-394.
20. Fuster, V., P. M. Steele, W. D. Edwards, B. J. Gersh, M. D. McGoon, and R. L. Frye. 1984. Primary pulmonary hypertension: natural history and the importance of thrombosis. Circulation 70:580-587.
21. D'Alonzo, G. E., R. J. Barst, S. M. Ayres, E. H. Bergofsky, B. H. Brundage, K. M. Detre, A. P. Fishman, R. M. Goldring, B. M. Groves. J. T. Kernis, P. S. Levy, G. G. Pietra, L. M. Reid, J. T. Reeves, S. Rich, C. E. Vreim, G. W. Williams, and M. Wu. 1991. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern. Med. 115:343-349.
22. Sandoval, J., O. Bauerle, A. Palomar, A. Gomez, M. L. Martinez Guerra, M. Beltran, and M. L. Guerrero. 1994. Survival in primary pulmonary hypertension. Validation of a prognostic equation. Circulation 89:1733-1744.
23. Louis, M., J. B. Thorens, and J. C. Chevrolet. 1993. Calcium-channel blockers testing for primary pulmonary hypertension associated with HIV infection (abstract). Am. Rev. Respir. Dis. 147:A536.
24. Currie, P. J., J. B. Seward, K. L. Chan, D. A. Fyfe, D. J. Hagler, D. D. Mair, G. S. Reeder, R. A. Nishimura, and A. J. Tajik. 1985. Continuous wave Doppler determination of right ventricular pressure: a simultaneous Doppler-catheterization study in 127 patients. J. Am. Coll. Cardiol. 6:750-756.
25. Campbell, M. J., and M. J. Gardner. 1989. Calculating confidence intervals for some non-parametric analyses. In M. J. Gardner and D. G. Altman, editors. Statistics with Confidence. British Medical Journal, London. 71-79.
26. Pantaleo, G., and A. S. Fauci. 1995. New concepts in the imunopathogenesis of HIV infection. Annu. Rev. Immunol. 13:487-512.
27. Cohen, O. J., G. Pantaleo, M. Holodniy, S. Schnittman, M. Niu, C. Graziosi, G. N. Pavlakis, J. Lalezari, J. A. Bartlett, R. T. Steigbigel. J. Cohn, R. Novak, D. McMahon, and A. S. Fauci. 1995. Decreased human immuodeficiency virus type 1 plasma viremia during antiretroviral therapy reflects downregulation of viral replication in lymphoid tissue. Proc. Natl. Acad. Sci. U.S.A. 92:6017-6021.
28. Rich, S., E. Kaufmann, and P. S. Levy. 1992. The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension. N. Engl. J. Med. 327:76-81.
29. Barst, R. J., L. J. Rubin, W. A. Long, M. D. McGoon, S. Rich, D. B. Badesch, B. M. Groves, V. F. Tapson, R. C. Bourge, B. H. Brundage, S. K. Koerner, D. Langleben, C. A. Keller, B. F. Uretsky, L. M. Clayton, M. M. Jobsis, S. D. Blackburn, Jr., D. Shortino, J. W. Crow, and the Primary Pulmonary Hypertension Study Group. 1996. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. N. Engl. J. Med. 334:296-302.
30. Rich, S., and E. Kaufmann. 1991. High dose titration of calcium channel blocking agents for primary pulmonary hypertension: guidelines for short-term drug testing. J. Am. Coll. Cardiol. 18:1323-1327.
31. Asherson, R. A., T. W. Higenbottam, A. T. Dinh Xuan, M. A. Khamashta, and G. R. Hughes. 1990. Pulmonary hypertension in a lupus clinic: experience with twenty-four patients. J. Rheumatol. 17:1292-1298.
32. Muir, K. W. I. B. Squire, W. Alwan, and K. R. Lees. 1994. Anticardiolipin antibodies in an unselected stroke population. Lancet 344:452-456.
33. Maclean, C., P. J. Flegg, and D. C. Kilpatrick. 1990. Anti-cardiolipin antibodies and HIV infection. Clin. Exp. Immunol. 81:263-266.
34. Stimmler, M. M., F. P. J. Quismorio, W. G. McGehee, T. Boylen, and O. P. Sharma. 1989. Anticardiolipin antibodies in acquired immunodeficiency syndrome. Arch. Intern. Med. 149:1833-1835.
35. Argov, S., A. Schattner, R. Burstein, Z. T. Handzel, Y. Shoenfeld, and Z. Bentwich. 1991. Autoantibodies in male homosexuals and HIV infection. Immunol. Lett. 30:31-35.